Jane Street Group, LLC Cerus Corp Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$4.81 - $6.99 $74,555 - $108,345	-15,500 Reduced 45.19%	18,800 $103,000
Q4 2021 Feb 15, 2022	BUY	$5.97 - $7.93 $18,507 - $24,583	3,100 Added 9.94%	34,300 $234,000
Q3 2021 Nov 16, 2021	SELL	$4.79 - $6.68 $174,835 - $243,820	-36,500 Reduced 53.91%	31,200 $190,000
Q2 2021 Aug 16, 2021	BUY	$5.35 - $6.35 $50,290 - $59,690	9,400 Added 16.12%	67,700 $400,000
Q1 2021 May 18, 2021	SELL	$5.68 - $7.87 $86,904 - $120,411	-15,300 Reduced 20.79%	58,300 $350,000
Q4 2020 Feb 17, 2021	BUY	$5.25 - $8.56 $254,100 - $414,304	48,400 Added 192.06%	73,600 $509,000
Q2 2020 Aug 17, 2020	BUY	$4.5 - $7.02 $113,400 - $176,904	25,200 New	25,200 $166,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $319M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.